Aerovate Therapeutics Stock Downgraded After Trial Setback
Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
- Latest
- Trending
Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.
Seatrade acquires state-of-the-art Ship-to-Shore (STS) cranes, boosting port efficiency. Copyright © 2024, Informa Markets (UK) Limited.
Social media buzzes with a writer's AI lament, probing ethics in AI’s personhood, usage, and impact on life and warfare, ...
The dollar's steady decline meets a rising yuan, now dominant in Moscow Exchange. Bitcoin emerges as the new Bretton Woods.
Explore a range of Ethereum staking plans, from free trials to premium options with substantial rewards, optimal for investment returns.
Dow Inc. leads global LDPE production with 2.6MM tons capacity; Univation dominates PE tech, supplying over one-third of global HDPE ...
At the close in Saudi Arabia, the index declined 1.31%, hitting a 6-month low with Saudi Manpower down 8.51%, while ...
Nexalin shares are 1% shorted; 52-week range $0.25-$3.40. Market cap: $6.69M, PE ratio: -1.36, beta: 5.13. Qtr EPS: -$0.10; ROE: ...
Professor Kenneth O's 15-year effort culminates in 2022 with a THz radiation imaging chip, enhancing portability and offering new application ...
BTC cloud mining is a viable alternative for increasing passive income by validating transactions on the Bitcoin blockchain. Learn how ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.